Adage Capital Partners GP L.L.C. Buys 4,000 Shares of HealthEquity, Inc. $HQY

Adage Capital Partners GP L.L.C. lifted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 50.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,000 shares of the company's stock after buying an additional 4,000 shares during the quarter. Adage Capital Partners GP L.L.C.'s holdings in HealthEquity were worth $1,060,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Ieq Capital LLC raised its stake in HealthEquity by 4.4% during the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock valued at $260,000 after purchasing an additional 123 shares during the last quarter. Xponance Inc. raised its stake in HealthEquity by 1.1% during the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after purchasing an additional 136 shares during the last quarter. Fifth Third Bancorp raised its stake in HealthEquity by 17.5% during the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock valued at $84,000 after purchasing an additional 142 shares during the last quarter. State of Wyoming raised its stake in HealthEquity by 2.9% during the 1st quarter. State of Wyoming now owns 5,915 shares of the company's stock valued at $523,000 after purchasing an additional 169 shares during the last quarter. Finally, Greenleaf Trust raised its stake in HealthEquity by 7.8% during the 1st quarter. Greenleaf Trust now owns 2,407 shares of the company's stock valued at $213,000 after purchasing an additional 175 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.50% of the company's stock.

HealthEquity Price Performance

Shares of HQY traded up $0.15 during trading hours on Friday, hitting $92.49. The stock had a trading volume of 616,085 shares, compared to its average volume of 1,219,389. The company's fifty day moving average is $93.46 and its two-hundred day moving average is $94.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The stock has a market capitalization of $7.97 billion, a price-to-earnings ratio of 56.05, a P/E/G ratio of 1.32 and a beta of 0.50.

Analyst Upgrades and Downgrades

HQY has been the subject of several research analyst reports. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. The Goldman Sachs Group upped their target price on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research note on Wednesday, June 4th. Barrington Research reissued an "outperform" rating and issued a $125.00 price target on shares of HealthEquity in a report on Friday, August 29th. Finally, Jefferies Financial Group boosted their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $119.77.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.